| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Center for Complementary and Alternative Medicine (NCCAM) |
| Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
| ClinicalTrials.gov Identifier: | NCT00079534 |
Purpose
The purpose of this study is to determine whether individuals praying at a distance (also known as "Distant Healing") can positively affect the health of people with HIV/AIDS.
| Condition | Intervention |
|
HIV Infections AIDS |
Behavioral: Non-local/distant healing or prayer |
| MedlinePlus related topics: | AIDS |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
| Official Title: | Distant Healing Efforts for AIDS by Nurses and "Healers" |
| Estimated Enrollment: | 150 |
| Study Start Date: | December 2000 |
| Estimated Study Completion Date: | December 2003 |
Significant numbers of people with HIV/AIDS seek spiritual or “psychic" treatment. Distant healing could potentially be of benefit to large numbers of HIV/AIDS patients, as it is widely available and requires no travel or other activity on the part of the patient. However, the treatment can be costly and has not yet been proven effective in a controlled clinical trial. This study will evaluate the efficacy of distant healing in patients with HIV/AIDS.
Participants in this study will be randomly assigned to either the distant healing group or a control group. All participants will have hour-long study visits at entry and Months 6 and 12. At study visits, participants will complete a demographic questionnaire, self-report health and symptom inventory, quality of life assessment, and profile of mood states. Blood will be drawn at each study visit.
Eligibility
| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion criteria
Exclusion criteria
Contacts and Locations| United States, California | |||||
| California Pacific Medical Center | |||||
| San Francisco, California, United States, 94115 | |||||
| Principal Investigator: | Donald Abrams, MD | University of California, San Francisco |
| Study Director: | Jerome J. Stone, MA, RN | California Pacific Medical Center |
More Information
| Study ID Numbers: | R01 AT000485-01 |
| First Received: | March 9, 2004 |
| Last Updated: | August 16, 2006 |
| ClinicalTrials.gov Identifier: | NCT00079534 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
